Compare StocksISRG vs ORCL

Intuitive Surgical, Inc. (ISRG) vs Oracle Corporation (ORCL): Which Is the Better Buy in 2026?

As of 2026-08-03, ISRG is overvalued at $353, with a DCF intrinsic value of $214 and a margin of safety of -65%. ORCL is undervalued at $130, with an intrinsic value of $404 and a margin of safety of 68%. Of the two, ORCL has the wider margin of safety.

ISRG
Intuitive Surgical, Inc.
$353.33
VS
ORCL
Oracle Corporation
$129.87

Rewards

ISRG
  • Gross margin of 66.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Intuitive Surgical, Inc. scores 89/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Free cash flow has grown at a 37.5% CAGR over the past 4 years, demonstrating strong earnings power growth.
ORCL
  • Gross margin of 65.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Return on equity has consistently exceeded 20% over 4 years, indicating efficient use of shareholder capital.
  • Each dollar of retained earnings has created $3.80 of earning power — management is an exceptional capital allocator.

Risks

ISRG
  • FCF yield of 2.1% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • 8 insider sales totaling $2.8M with no purchases in the past 3 months — insiders are reducing their exposure.
ORCL
  • Despite buyback spending, shares outstanding increased in 3 out of 4 years — stock-based compensation is offsetting repurchases.
  • High leverage (3.15x net debt/equity) combined with thin interest coverage (-1.0x) poses financial risk.
  • Net debt/EBITDA of 4.4x indicates heavy leverage — it would take over 4 years of EBITDA to pay off net debt.

Key Valuation Metrics

Learn more →
ISRG
ORCL
Valuation
$2.62B
Free Cash Flow
$-24.54B
2.07%
FCF Yield
-6.56%
40.47
Trailing P/E
22.28
29.27
Forward P/E
11.93
Quality & Moat
N/A
ROIC
9.15%
17.42%
ROE
53.38%
66.68%
Gross Margin
65.82%
1.73
PEG Ratio
0.73
Balance Sheet Safety
N/A
Net Debt / Equity
3.15
No debt
Interest Coverage
N/A
-1.25
Net Debt / EBITDA
4.44
0.00%
Dividend Yield
1.54%
ISRG: 3Ties: 1ORCL: 5
ISRGORCL

Historical Fundamentals

Learn more →
ISRG

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

ORCL

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ISRG
Not enough historical data to compute the retained earnings test.
ORCL
$3.51
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$25.08B
Δ Market Cap
+$87.99B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ISRG
65.4% Overvalued
Price is 65.4% above estimated fair value
Current Price: $353.33
Fair Value: $213.67
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
ORCL
67.8% Margin of Safety
Price is 67.8% below estimated fair value
Current Price: $129.87
Fair Value: $403.51
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ISRG

What growth rate is the market pricing in at $353?

+19.2%
Market-Implied FCF Growth Rate

Market below historical growth — potential opportunity.

ORCL

Requires positive FCF to compute implied growth rate.

Economic Moat Score

Learn more →
ISRG
89/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
ORCL
67/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving reinvestment efficiency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ISRG

Insufficient data for Beneish M-Score calculation (requires 2+ years).

ORCL
-2.58
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ISRG
Insiders 0.5%Institutions 89.3%Retail & Other 10.1%
No. of Institutional Holders3,147
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
ORCL
Insiders 40.5%Institutions 43.9%Retail & Other 15.6%
No. of Institutional Holders4,502
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ISRG
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
ORCL
0
Buys (3M)
0
Buys (12M)
FAIRHEAD RONA ALISON
Director
$112,258
@ $233.87 · 2025-07-07
MOORMAN CHARLES W IV
Director
$947,913
@ $172.35 · 2025-02-12
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ISRG
8
Sells (3M)
32
Sells (12M)
Total value (12M): $69.28M
BROSIUS MARK PRESTON
Officer
$29,954
@ $356.60 · 2026-07-29
BROSIUS MARK PRESTON
Officer
$19,833
@ $413.19 · 2026-06-12
BROSIUS MARK PRESTON
Officer
$29,104
@ $421.80 · 2026-06-10
LOEB GARY
Officer
$169,656
@ $424.14 · 2026-06-10
JEDDI IMAN
Officer
$2.37M
@ $420.55 · 2026-06-01
BROSIUS MARK PRESTON
Officer
$15,945
@ $442.92 · 2026-05-22
BROSIUS MARK PRESTON
Officer
$23,464
@ $434.52 · 2026-05-20
LOEB GARY
Officer
$178,780
@ $446.95 · 2026-05-11
LADD AMY L
Director
$291,886
@ $471.54 · 2026-04-29
CURET MCADAMS MYRIAM J
Officer
$51,865
@ $493.95 · 2026-03-10
BROSIUS MARK PRESTON
Officer
$630,475
@ $487.61 · 2026-03-09
BROSIUS MARK PRESTON
Officer
$1.82M
@ $496.19 · 2026-03-05
WIDMAN FREDRIK
Officer
$181,915
@ $495.68 · 2026-03-03
WADORS PATRICIA L.
Officer
$109,936
@ $499.71 · 2026-02-27
WIDMAN FREDRIK
Officer
$65,830
@ $494.96 · 2026-02-11
CURET MCADAMS MYRIAM J
Officer
$65,523
@ $520.02 · 2026-01-29
CURET MCADAMS MYRIAM J
Officer
$122,500
@ $532.61 · 2026-01-27
BROSIUS MARK PRESTON
Officer
$2.72M
@ $547.47 · 2025-12-15
BROSIUS MARK PRESTON
Officer
$2.63M
@ $547.36 · 2025-12-12
CURET MCADAMS MYRIAM J
Officer
$58,230
@ $559.90 · 2025-12-10
GUTHART GARY S
Officer and Director
$13.02M
@ $570.89 · 2025-12-01
CURET MCADAMS MYRIAM J
Officer
$71,124
@ $568.99 · 2025-12-01
BARRATT CRAIG H
Director
$435,000
@ $580.00 · 2025-11-12
CHARLTON HENRY L
Officer
$7.96M
@ $580.00 · 2025-11-12
MILLER BRIAN EDWARD
Officer
$2.01M
@ $575.00 · 2025-11-10
CURET MCADAMS MYRIAM J
Officer
$58,800
@ $560.00 · 2025-11-10
WIDMAN FREDRIK
Officer
$1.14M
@ $550.00 · 2025-11-05
CURET MCADAMS MYRIAM J
Officer
$4.22M
@ $548.34 · 2025-10-29
BARRATT CRAIG H
Director
$1.20M
@ $548.01 · 2025-10-24
ROSA DAVID J
Chief Executive Officer
$13.41M
@ $547.55 · 2025-10-24
LADD AMY L
Director
$305,588
@ $455.42 · 2025-09-04
GUTHART GARY S
Officer and Director
$13.87M
@ $472.49 · 2025-08-29
CURET MCADAMS MYRIAM J
Officer
$2.22M
@ $492.48 · 2025-07-25
BROSIUS MARK PRESTON
Officer
$242,182
@ $561.91 · 2025-06-06
BROSIUS MARK PRESTON
Officer
$355,139
@ $550.60 · 2025-06-04
BROSIUS MARK PRESTON
Officer
$23,596
@ $561.81 · 2025-05-16
BROSIUS MARK PRESTON
Officer
$36,886
@ $558.88 · 2025-05-14
SAMATH JAMIE E.
Chief Financial Officer
$483,074
@ $527.95 · 2025-05-02
NACHTSHEIM JAMI DOVER K
Director
$1.25M
@ $520.00 · 2025-05-01
LADD AMY L
Director
$4.44M
@ $505.55 · 2025-04-30
DESANTIS ROBERT
Officer
$508,509
@ $513.65 · 2025-04-29
CURET MCADAMS MYRIAM J
Officer
$2.05M
@ $513.18 · 2025-04-25
LOEB GARY
Officer
$872,406
@ $513.18 · 2025-04-25
DESANTIS ROBERT
Officer
$5.76M
@ $499.22 · 2025-03-13
MILLER BRIAN EDWARD
Officer
$6.37M
@ $493.44 · 2025-03-12
BROSIUS MARK PRESTON
Officer
$260,725
@ $533.18 · 2025-03-07
BROSIUS MARK PRESTON
Officer
$824,991
@ $558.94 · 2025-03-06
ROSA DAVID J
President
$9.20M
@ $557.52 · 2025-03-05
BROSIUS MARK PRESTON
Officer
$282,300
@ $573.78 · 2025-03-03
CURET MCADAMS MYRIAM J
Officer
$1.75M
@ $577.30 · 2025-03-03
WIDMAN FREDRIK
Officer
$464,762
@ $573.78 · 2025-03-03
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
ORCL
1
Sells (3M)
15
Sells (12M)
Total value (12M): $126.77M
HENLEY JEFFREY O
Officer and Director
$63.66M
@ $159.16 · 2026-06-24
LEVEY STUART A
Officer
$2.64M
@ $176.19 · 2026-04-16
MAGOUYRK CLAYTON M
Chief Executive Officer
$1.55M
@ $155.23 · 2026-02-09
KEHRING DOUGLAS A
Officer
$6.82M
@ $194.89 · 2026-01-15
HURA MARK
Officer
$2.95M
@ $196.89 · 2025-12-24
SELIGMAN NAOMI O
Director
$437,064
@ $196.61 · 2025-12-23
MAGOUYRK CLAYTON M
Chief Executive Officer
$1.93M
@ $192.52 · 2025-12-19
SMITH MARIA
Officer
$2.80M
@ $280.31 · 2025-10-23
MAGOUYRK CLAYTON M
Chief Executive Officer
$11.07M
@ $276.64 · 2025-10-21
LEVEY STUART A
Officer
$5.93M
@ $300.00 · 2025-10-10
SELIGMAN NAOMI O
Director
$641,958
@ $288.91 · 2025-09-26
SICILIA MICHAEL D
Officer
$10.87M
@ $321.16 · 2025-09-23
SICILIA MICHAEL D
Officer
$5.12M
@ $313.60 · 2025-09-16
MAGOUYRK CLAYTON M
President
$6.31M
@ $297.11 · 2025-09-12
SICILIA MICHAEL D
Officer
$4.04M
@ $254.48 · 2025-08-05
SELIGMAN NAOMI O
Director
$770,656
@ $233.32 · 2025-07-16
SMITH MARIA
Officer
$2.33M
@ $232.99 · 2025-07-03
CATZ SAFRA A
Chief Executive Officer
$267.24M
@ $212.01 · 2025-06-27
CATZ SAFRA A
Chief Executive Officer
$794.64M
@ $212.50 · 2025-06-26
CATZ SAFRA A
Chief Executive Officer
$764.01M
@ $206.77 · 2025-06-23
MAGOUYRK CLAYTON M
Officer
$3.21M
@ $214.10 · 2025-06-17
CONRADES GEORGE HENRY
Director
$1.74M
@ $213.49 · 2025-06-17
SELIGMAN NAOMI O
Director
$428,562
@ $149.53 · 2025-05-05
SELIGMAN NAOMI O
Director
$291,620
@ $145.81 · 2025-04-02
CATZ SAFRA A
Chief Executive Officer
$705.46M
@ $185.40 · 2025-01-24
SMITH MARIA
Officer
$1.04M
@ $165.00 · 2024-09-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ISRG
FearGreed
😨Fear(31/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
ORCL
FearGreed
😨Fear(33/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ISRG
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (31)
ORCL
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (33)
View ISRG Full AnalysisView ORCL Full Analysis

Frequently Asked Questions: ISRG vs ORCL

Is Intuitive Surgical, Inc. or Oracle Corporation more undervalued in 2026?

Based on our discounted cash flow model, ORCL trades at a 67.8% margin of safety (intrinsic value $404 vs. price $130), compared to ISRG's -65.4% margin of safety (intrinsic $214 vs. $353).

Which stock has a wider economic moat, Intuitive Surgical, Inc. or Oracle Corporation?

ISRG scores 89/100 (Wide moat), while ORCL scores 67/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Oracle Corporation in financial distress?

ORCL's Altman Z-Score of 1.6 places it in the Distress zone, signaling elevated bankruptcy risk. ISRG scores 49.8 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, Intuitive Surgical, Inc. or Oracle Corporation?

Intuitive Surgical, Inc. (ISRG) generates a 2.1% free cash flow yield, compared to Oracle Corporation's -6.6%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

ISRG vs ORCL: Which Is the Better Buy in 2026? | SafetyMargin.io